Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 150 results
A minimalist illustration of a brain and an MRI machine on a dark background.

May 28, 2026

Simulations + AI = faster brain MRI scans

Recent advancements in MRI technology are poised to significantly enhance brain imaging efficiency and accuracy. Researchers at the Institute for Neurosciences CSIC-UMH have developed a method that combines simulations with artificial intelligence to reduce the time needed for MRI scans, enabling the integration of more sophisticated imaging techniques.This innovative approach not only accelerates scan times but also mitigates biases typically found in traditional clinical datasets. By leveragin
A diagnostic test kit on a lab countertop with a petri dish in the background.

May 27, 2026

IDXX: AI-driven innovation and expanding diagnostics platforms are propelling strong growth and sector leadership

IDEXX Laboratories is experiencing notable growth, driven by a strategic focus on innovation and the integration of advanced diagnostics and software solutions. The company's new CEO is implementing a purpose-driven strategy that emphasizes global expansion and the development of integrated diagnostic platforms. Key innovations such as inVue Dx and Cancer Dx are enhancing IDEXX's market position, showcasing strong adoption and expanding capabilities within the diagnostics sector. With a promisin
A minimalist representation of a microscope lens in flat design.

May 27, 2026

NIT Rourkela Develops AI-Enabled Autofocusing Technology for Microscopic Imaging

Researchers at NIT Rourkela have unveiled an innovative AI-enabled autofocusing technology aimed at enhancing microscopic imaging for biomedical diagnostics. This development, in partnership with Glowvista Instruments, addresses key challenges faced by traditional microscopy systems, such as manual focus adjustments that can lead to diagnostic inaccuracies and delays.The newly patented technology, titled “A Method for Autofocusing in Optofluidic Microsystems and Processes,” integrates deep learn
An MRI machine in a dimly lit hospital imaging room with a patient on the table.

May 27, 2026

Diagnostic Imaging Market Expected to Reach US$68.81 Billion by 2034 as AI-Powered Technologies Transform Healthcare Diagnostics

The diagnostic imaging market is on track to reach approximately US$68.81 billion by 2034, driven by advancements in AI and increasing healthcare demands.As chronic illnesses rise and the emphasis on preventive care intensifies, diagnostic imaging has become crucial in clinical decision-making. Various imaging technologies, such as X-rays, MRIs, and CT scans, enable healthcare professionals to accurately visualize internal structures, facilitating early disease detection and better patient outco
A minimalist illustration of a microscope with a lens in a dark color scheme.

May 26, 2026

NIT Rourkela Develops AI-Enabled Microscopy For Next-Generation Healthcare Diagnostics

Researchers at NIT Rourkela have developed an innovative AI-enabled microscopy technology aimed at enhancing biomedical diagnostics.This new autofocusing technology, patented under the title ‘A Method for Autofocusing in Optofluidic Microsystems and Processes,’ is designed to address the limitations of conventional microscopy systems, which often rely on manual adjustments that can introduce errors and delays in diagnosis. The team, led by Prof. Earu Banoth and collaborating with Glowvista Instr
Minimalist illustration of a microscope representing AI-powered microscopy.

May 26, 2026

NIT Rourkela develops AI-powered microscopy for disease detection

Researchers at the National Institute of Technology (NIT), Rourkela have introduced an innovative AI-driven autofocusing microscopy technology aimed at enhancing biomedical diagnostics. This development could revolutionize the detection of diseases such as acute lymphoblastic leukaemia and malaria, making healthcare diagnostics more accessible and efficient in India.The new system, created in partnership with Glowvista Instruments, showcases the potential for rapid and precise imaging with minim
A flat illustration of a pathology slide with an AI brain overlay, symbolizing digital pathology.

May 26, 2026

Roche to Acquire PathAI to Expand Digital Pathology and AI Diagnostics

Roche has announced its intent to acquire PathAI for $750 million, aiming to enhance its digital pathology and AI diagnostic capabilities.The acquisition, which follows a partnership initiated in 2021, is designed to integrate PathAI’s advanced AI technologies and image management systems into Roche's laboratory workflows. This merger is expected to transition traditional manual processes to automated, AI-enhanced operations, thereby improving diagnostic efficiency and accuracy in pathology.By i
flat design of a radiology imaging device

May 26, 2026

Jardine Matheson Expands Into Healthcare AI With I-MED Buy

Jardine Matheson is making a significant foray into healthcare AI with its acquisition of I-MED Radiology Network, a move that signals a strategic pivot for the traditionally diversified conglomerate.Valued at A$3.4 billion (US$2.4 billion), this acquisition grants Jardine access to one of Australia’s largest diagnostic imaging providers, positioning the company to leverage the burgeoning field of artificial intelligence in healthcare. Notably, the deal also secures a minority stake in Harrison.
A minimalist illustration of a microscope and a cell sample in flat design.

May 25, 2026

Roche Enters Into a Definitive Merger Agreement to Acquire PathAI to Transform AI-Driven Diagnostics

Roche has entered a definitive merger agreement to acquire PathAI, aiming to enhance AI-driven diagnostics in pathology.The acquisition of PathAI, a leader in digital pathology and AI technology, is set to bolster Roche's existing capabilities in companion diagnostics. This move follows a successful partnership initiated in 2021, which has now evolved to include the development of AI-enabled diagnostic algorithms. The deal is expected to close in the latter half of the year, after which PathAI w
A minimalist representation of a smart otoscope for pediatric healthcare.

May 24, 2026

EarSmartAI: Pre-Seed Investment To Advance AI-Powered Pediatric Ear Infection Diagnostics

EarSmartAI has secured a $250,000 pre-seed investment from Boomerang Ventures to enhance its AI-driven diagnostic platform for pediatric ear infections. This funding comes as the company aims to meet the rising demand for efficient pediatric healthcare solutions.Located in Indianapolis, EarSmartAI is developing a connected care platform that allows parents to evaluate potential ear infections at home. Utilizing a smart otoscope, proprietary AI algorithms, and a mobile app, the platform targets t
Flat design of a medical imaging device

May 24, 2026

Siemens Healthineers Wins FDA Nod for AI Imaging Suite as Diagnostics Crisis and Spin-Off Plan Domin

Siemens Healthineers has received FDA approvals for its AI imaging technology, but faces challenges in its diagnostics division.Siemens Healthineers recently achieved six regulatory approvals for its Artis interventional imaging portfolio, marking a significant advancement for its Optiq AI imaging chain, which enhances image quality using deep learning. However, this positive development contrasts sharply with the ongoing struggles in its diagnostics unit, which experienced a 6.5% revenue declin
A tissue sample on a microscope slide in a lab setting

May 21, 2026

Roche to Acquire PathAI to Drive Diagnostics

Roche has announced its intent to acquire PathAI, a leader in digital pathology and AI diagnostics, in a move aimed at enhancing its capabilities in precision medicine.The acquisition, which follows a successful partnership initiated in 2021, will allow Roche to integrate PathAI's advanced digital pathology tools into its existing oncology diagnostic platforms. This integration is expected to streamline diagnostic workflows by transforming traditional manual processes into automated, AI-driven o